Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.3098
+0.0098 (3.27%)
May 18, 2026, 1:40 PM EST

Avenue Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1242619
Market Cap Growth
-47.44%-47.28%92.60%-61.53%-70.79%-80.95%
Enterprise Value
-1-311518
Last Close Price
0.310.682.0012.0887.001021.50
PS Ratio
0.731.54----
PB Ratio
0.851.182.213.261.705.50
P/TBV Ratio
0.851.181.471.351.425.50
Net Debt / Equity Ratio
-2.02-1.56-1.40-2.73-2.05-1.09
Asset Turnover
0.460.50----
Quick Ratio
1.902.603.181.491.877.57
Current Ratio
1.942.673.281.551.917.78
Return on Equity (ROE)
-101.08%-159.82%-931.95%-535.10%-107.28%-128.43%
Return on Assets (ROA)
-43.20%-73.31%-311.89%-209.03%-93.05%-64.85%
Return on Capital Employed (ROCE)
-174.90%-179.40%-607.90%-2223.20%-246.30%-108.30%
Earnings Yield
-171.63%-134.34%-283.65%-486.53%-64.07%-19.66%
Buyback Yield / Dilution
-69.28%-141.75%-817.14%-384.72%-92.83%-2.98%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.